Search Within

Subhiksha Nandakumar

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (19)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. GSK Faculty (47)
  2. Human Oncology and Pathogenesis Program (47)
  3. Department of Medicine (35)
  4. Department of Pathology and Laboratory Medicine (35)
  5. Solid Tumor Oncology Division (35)
  6. Epidemiology and Biostatistics (34)

More Groups

People
  1. Nikolaus Schultz (30)
  2. Michael Berger (22)
  3. David Solit (20)
  4. Ingo Mellinghoff (17)
  5. Angela Brannon (15)
  6. Marc Ladanyi (15)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (2)
  6. 2020 (7)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Neuro-Oncology (7)
  3. Cancer Research (6)
  4. Journal of Clinical Oncology (4)
  5. Cancer Discovery (2)
  6. European Urology (2)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Oxford University Press (8)
  3. Nature Publishing Group (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tumor MHC class I expression associates with intralesional IL2 response in melanoma
    Journal Article

    Pourmaleki, M.; Jones, C. J.; Ariyan, C. E.; Zeng, Z.; Pirun, M.; Navarrete, D. A.; Li, Y.; Zhang, M.; Nandakumar, S.; Campos, C.; more...
    Cancer Immunology Research (2022)

    Fulltext@MSK | Save
  • Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer
    Journal Article

    Mazzu, Y. Z.; Liao, Y. R.; Nandakumar, S.; Jehane, L. E.; Koche, R. P.; Rajanala, S. H.; Li, R.; Zhao, H. Y.; Gerke, T. A.; Chakraborty, G.; more...
    Oncogene (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integration of genomic and clinical data from 25,000 patients identifies molecular determinants of metastatic potential and organotropisms
    Meeting Abstract

    Nguyen, B.; Fong, C.; DiNatale, R.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Rajanna, A.; Solit, D. B.; Berger, M. F.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integrative analysis of clinical and genomic information identifies predictive markers of metastatic risk
    Meeting Abstract

    Fong, C. J.; Sanchez-Vega, F.; Ngyuen, B.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W.; Rajanna, A.; Zehir, A.; Berger, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save